Last Updated on December 16, 2024 by The Health Master
DCGI
The All India Pharmaceutical Association Consortium (AIPAC) is set to revolutionize the Indian pharmaceutical industry with its inauguration by Dr. Rajeev Singh Raghuvanshi, the Drugs Controller General of India (DCGI).
This groundbreaking initiative is specifically designed to uplift Micro, Small, and Medium Enterprises (MSMEs) in the sector, fostering skill development and scientific excellence.
A Collaborative Effort for Industry Growth
AIPAC, in collaboration with the following is poised to bridge the knowledge gap for MSMEs:
- Society for Pharmaceutical Dissolution Science (SPDS),
- Indian Drug Manufacturers’ Association-MP State Board (IDMA-MP), and
- Madhya Pradesh State Drugs and Pharmaceutical Manufacturers Association (MPSDMA)
This strategic partnership aims to empower these enterprises to produce high-quality medicines that meet global standards.
Addressing the Needs of MSME Professionals
Recognizing the challenges faced by MSME professionals, particularly in terms of accessibility to high-quality training and development opportunities, AIPAC’s initiative offers a much-needed solution.
The program will provide specialized training and coaching, enabling MSMEs to navigate the complexities of the pharmaceutical industry and comply with evolving regulatory standards.
Key Focus Areas of the Program
The event, scheduled for December 12, 2024, at the Prestige Institute of Management & Research, Indore, will delve into critical aspects of pharmaceutical science and technology.
Key topics to be covered include:
- Dissolution Science and Technology: Understanding the fundamental principles and latest advancements in dissolution testing.
- Regulatory Compliance: Navigating the complex regulatory landscape and ensuring adherence to industry standards.
- Quality Assurance and Control: Implementing robust quality management systems to maintain product excellence.
- Research and Development: Fostering innovation and driving the development of new pharmaceutical products.
Expert Insights and Panel Discussions
The event will feature renowned experts from the pharmaceutical industry, including Dr. Rajeev Singh Raghuvanshi, the Drugs Controller General of India (DCGI).
Renowned experts like Dr. Padma Devarajan, President of SPDS, will share insights on the importance of dissolution science.
A panel discussion on “What Care Needs to Be Taken During Dissolution Testing? Common Flaws” will bring together industry leaders to address common challenges and best practices.
Why Attend?
- Skill Enhancement: Gain valuable knowledge and skills to elevate your professional capabilities.
- Networking Opportunities: Connect with industry peers, experts, and potential collaborators.
- Regulatory Updates: Stay informed about the latest regulatory requirements and guidelines.
- Career Advancement: Advance your career by acquiring cutting-edge knowledge and certifications.
By participating in this transformative event, you can contribute to the growth and success of the Indian pharmaceutical industry.
Who can attend the event?
Pharmaceutical professionals from MSMEs
Quality assurance, quality control, R&D, and regulatory affairs personnel
Students and faculty from pharmaceutical colleges and universities
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Key Notes on Revised Schedule M: Must read
Important short notes for Industry and Regulators
CDSCO Guidelines on Drug Recall
Quality Assurance Vs Quality Control in the Pharma Industry
Major FDA audit findings about Equipment and Instruments
Understanding GMP, cGMP, and WHO-GMP
Quality Assurance in the Pharmaceutical Industry
Duties and responsibilities of QA person in Pharma Industry
Difference: Disintegration and Dissolution test in pharma industry
Understanding DQ, IQ, PQ, and OQ in the Pharma Industry
Key Notes on Revised Schedule M: Point No. 5 – Qualification and validation
CDSCO directs expedited Approval of Rare Disease Drugs and Medical Devices
CDSCO approves Robotic System for Telesurgery
MN Sridhar has been appointed as Director of Drug Control Administration: Tamil Nadu
NPPA approves price increase for 11 Drugs
Four arrested for supplying Spurious Drugs to Maharashtra Hospital
Key Notes on Revised Schedule M: Point No. 4 – Sanitation and Hygiene
Wearable Medical device: The Future of Heart Health Monitoring
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
